alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 60, Number 75 (Wednesday, April 19, 1995)]
[Notices]
[Page 19595]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-9619]



-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Committee on Vital and Health Statistics (NCVHS) 
Subcommittee on Medical Classification Systems: Meeting

    Pursuant to Pub. L. 92-463, the National Center for Health 
Statistics (NCHS), Centers for Disease Control and Prevention (CDC), 
announces the following meeting.

    Name: NCVHS Subcommittee on Medical Classification Systems.
    Time and Date: 9 a.m.-5 p.m., May 16, 1995.
    Place: Room 703A, Hubert H. Humphrey Building, 200 Independence 
Avenue, SW, Washington, D.C. 20201.
    Status: Open.
    Purpose: The subcommittee will discuss: the procedure 
classification systems for managed care; replacement for the 
International Classification of Diseases-9-Clinical Modification, 
Volume III, revision of Physicians' Current Procedural Terminology 
4; and discuss the subcommittee's work plan.
    Contact Person for More Information: Substantive program 
information as well as summaries of the meeting and a roster of 
committee members may be obtained from Gail F. Fisher, Ph.D., 
Executive Secretary, NCVHS, NCHS, CDC, Room 1100, Presidential 
Building, 6525 Belcrest Road, Hyattsville, Maryland 20782, telephone 
301/436-7050.

    Dated: April 13, 1995.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 95-9619 Filed 4-18-95; 8:45 am]
BILLING CODE 4163-18-M
#### NAOMI McM. LEDFORD, Admx., v. CITY OF WINSTON-SALEM, et al.

(Filed 31 January, 1947.)

Aepeal by plaintiff from *Carr, J.,*at October Term, 1946, of Forsyth.

Civil action to recover damages for death of plaintiff’s intestate, alleged to have been caused by the wrongful act, neglect or default of the defendants.

*699From judgment of nonsuit entered at tbe close of plaintiff’s evidence, she appeals, assigning errors.

*Hlledge <& Hayes and H. Bryce Parker for plaintiff, appellant.*

*Womble, Carlyle, Martin & Sandridge for defendant, City of Winston-Salem, appellee.*

*Craige <£ Craige and Kerr Craige Ramsay for defendant, Winston-Salem Railway Co., appellee.*

Per Curiam.

Tbe scene of tbe present accident is tbe same as tbat appearing in tbe case of *Dillon v. Winston-Salem, et al.,*reported in 221 N. C., 512, 20 S. E. (2d), 845, witb full description of tbe location, to wbieb reference may be bad to avoid repetition. Tbe essential and operative facts of tbe two cases are strikingly similar, except tbat in tbe *Dillon Case*plaintiff’s intestate was a passenger directing tbe operation of tbe automobile in wbieb be was riding, while bere plaintiff’s intestate was tbe driver of tbe death car. Both cases are controlled by tbe same principles of law, and both were dismissed on demurrer to the evidence in tbe Superior Court. Tbe judgment in tbe *Dillon Case*was affirmed on appeal, and a like result must follow bere. No useful purpose would be served by detailing again a parallel state of facts. *Alberty v. Greensboro,*219 N. C., 649, 14 S. E. (2d), 635.

Recognizing tbe pertinency of tbe Dillon decision, tbe plaintiff seeks to distinguish tbe subject case from tbat one, but tbe controlling facts are too nearly alike to warrant a different conclusion. Of course, there are differences in detail. These, however, are unimportant. This was tbe result reached in tbe Superior Court, and we are unable to say there is reversible error in tbe judgment.

Affirmed.
<PAGE>
                                                                    EXHIBIT 23.1

               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS

      We consent to the incorporation by reference in the Registration
Statements (Form S-8 Nos. 333-13773, 333-63967, 333-82323, 333-57362, 333-73562,
333-97265, 333-111000) of our report dated March 12, 2004, with respect to the
consolidated financial statements and schedule of Peerless Systems Corporation
included in the Annual Report (Form 10-K) for the year ended January 31, 2004.

                                         /s/ ERNST & YOUNG LLP

Los Angeles, California
April 30, 2004
**EXHIBIT
      32.2**





SECTION
      906 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF CANAM URANIUM
      CORP.





In
      connection with the accompanying Quarterly Report on Form 10-QSB of Canam
      Uranium Corp. for the quarter ended April 30, 2007, the undersigned, David
      Hayes, Chief Financial Officer of Canam Uranium Corp., does hereby certify
      pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
      Sarbanes-Oxley Act of 2002, that:





(1)
      such
      Quarterly Report on Form 10-QSB for the quarter ended July 31, 2007 fully
      complies with the requirements of Section 13(a) or 15(d) of the Securities
      Exchange Act of 1934, as amended; and





(2)
      the
      information contained in such Quarterly Report on Form 10-QSB for the quarter
      ended July 31, 2007 fairly presents, in all material respects, the financial
      condition and results of operations of Canam Uranium Corp.





Date:
      September 14, 2007





/s/
                David HayesDavid
                  HayesChief
                  Financial Officer
**EXHIBIT 32.2**

**SARBANES-OXLEY ACT SECTION 906CERTIFICATION**

In connection with this Quarterly Report on Form 10-Qof Foundation Coal Corporation for the period ended June 30, 2005, I,Frank J. Wood, Chief Financial Officer of Foundation Coal Corporation, herebycertify pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 ofthe Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

1.                This Form 10-Qfor the period ended June 30, 2005 fully complies with the requirements ofSection 13(a) or 15(d) of the Securities Exchange Act of 1934;and

2.                Theinformation contained in this Form 10-Q for the period ended June 30,2005 fairly presents, in all material respects, the financial condition andresults of operations of Foundation Coal Corporation.
| Date: September 6, 2005 |     | /s/ FRANK J.  WOOD        |
|------------------------------|----------|---------------------------|
|                         |     | Frank J. Wood             |
| * *                     | * * | *Chief Financial Officer* |

 

----
[Federal Register Volume 86, Number 104 (Wednesday, June 2, 2021)]
[Notices]
[Page 29591]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-11545]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Detection of HIV for Self-Testing 
(R61/R33 Clinical Trial Not Allowed).
    Date: June 24, 2021.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G33B, 
Rockville, MD 20892 (Virtual Meeting),
    Contact Person: John C. Pugh, Ph.D., Scientific Review Officer, 
Scientific Review Program, Division of Extramural Activities, 
National Institute of Allergy and Infectious Diseases, National 
Institutes of Health, 5601 Fishers Lane, Room 3G33B, Rockville, MD 
20852, (301) 435-2398, <a href="/cdn-cgi/l/email-protection#750500121d1f1a1d1b351606075b1b1c1d5b121a03"><span class="__cf_email__" data-cfemail="235356444b494c4b4d634050510d4d4a4b0d444c55">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: May 26, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-11545 Filed 6-1-21; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
[Federal Register Volume 61, Number 84 (Tuesday, April 30, 1996)]
[Notices]
[Page 19073]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-10628]



-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Center for Health Statistics; ICD-9-CM E Code Revisions

AGENCY: National Center for Health Statistics, Centers for Disease 
Control and Prevention (CDC), DHHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The National Center for Health Statistics has approved the 
following expansion to the External Cause Codes in the International 
Classification of Diseases, Ninth Revision, Clinical Modification (ICD-
9-CM). These ICD-9-CM E-Code revisions will become effective October 1, 
1996. The official guidelines for the application of E-codes for 
morbidity purposes will also be updated at that time. The official 
government version of the ICD-9-CM which will include all the revisions 
effective October 1, 1996, will be found on the ICD-9-CM CD-ROM which 
will be available through the Government Printing Office.

E967  Child and adult battering and other maltreatment
    E967.0  By father or stepfather
    E967.2  By mother or stepmother
    E967.3  By spouse or partner
    E967.4  By child
    E967.5  By sibling
    E967.6  By grandparent
    E967.7  By other relative
    E967.8  By non-related caregiver

FOR FURTHER INFORMATION CONTACT: Donna Pickett, R.R.A., Co-chair, ICD-
9-CM Coordination and Maintenance Committee, National Center for Health 
Statistics, CDC, telephone (301) 436-7050.

    Dated: April 24, 1996.
Joseph R. Carter,
Acting Associate Director for Management and Operations, Centers for 
Disease Control and Prevention (CDC).
[FR Doc. 96-10628 Filed 4-29-96; 8:45 am]
BILLING CODE 4163-18-P
NOTICE: NOT FOR OFFICIAL PUBLICATION. UNDER ARIZONA RULE OF THE SUPREME COURT 111(c), THIS DECISION IS NOT PRECEDENTIAL AND MAY BE CITED ONLY AS AUTHORIZED BY RULE

.

IN THE 

## A RIZONA 

## C OURT OF 

## A PPEALS

D IVISION O NE

STATE OF ARIZONA , Respondent ,

v.
DENNIS WATSON , JR. , P etitioner

. No. 1 CA

- CR 16

- 0837 PRPC

Petition for Review from the Superior Court in Maricopa County

No. CR2008

- 007760

- 005 The Honorable Steven P. Lynch , Judge Pro Tempore REVIEW GRANTED; RELI EF DENIED

COUNSEL Maricopa County Attorney's Office, Phoenix By Diane Meloche Counsel for Respondent

Dennis Watson , Jr., Eloy Petitioner

MEMORANDUM DECISION Presiding Judge Lawrence F. Winthrop, Judge Diane M. Johnsen and Judge Maria Elena Cruz delivered the decision of the Court. FILED 12-12-2017STATE v. WATSON Decision of the Court

2 PER CURIAM : ¶1 Petitioner Dennis Watson , Jr. seeks review of the superior court's order denying his petition for post

- conviction relief, filed pursuant to Arizona Rule of Criminal Procedure 32.1. This is petitioner's second petition. ¶2 Absent an abuse of discretion or error of law, this court will not disturb a superior court's ruling on a petition for p ost

- conviction relief. State v. Gutierrez , 229 Ariz. 573, 577, ¶ 19 (2012). It is petitioner's burden to show that the superior court abused its discretion by denying the petition for post

- conviction relief. See State v. Poblete , 227 Ariz. 537, ¶ 1 (App . 2011) (petitioner has burden of establishing abuse of discretion on review). ¶3 We have reviewed the record in this matter, the superior court's order denying the petition for post

- conviction relief, and the petition for review. We find that petitioner has not established an abuse of discretion. ¶4 For the foregoing reasons, we grant review and deny relief.
Exhibit 32.1

CERTIFICATIONS

In
connection with the Quarterly Report on Form 10-Q of Accentia Biopharmaceuticals, Inc. (the Company) for the three months ended June 30, 2009, as filed with the Securities and Exchange Commission on the date hereof (the Form
10-Q), I, Francis E. ODonnell, Jr., Chairman of the Board and Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that:

(1) The Form 10-Q fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as
amended; and

(2) The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of
operations of the Company.

Dated: August 16, 2010



|                                                        
|--------------------------------------------------------
|/s/ Francis E. ODonnell, Jr.                           
|Francis E. ODonnell, Jr., M.D.                         
|Chief Executive Officer; Chairman of the Board; Director

This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission, and is not to be
incorporated by reference into any filing of Accentia Biopharmaceuticals, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q),
irrespective of any general incorporation language contained in such filing.
[Federal Register Volume 61, Number 80 (Wednesday, April 24, 1996)]
[Notices]
[Pages 18146-18147]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-10045]



-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention


Board of Scientific Counselors, National Center for Infectious 
Diseases: Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting.

    Name: Board of Scientific Counselors, National Center for 
Infectious Diseases (NCID).
    Times and Dates: 10:30 a.m.-5:30 p.m., May 9, 1996. 8:30 a.m.-3 
p.m., May 10, 1996.
    Place: CDC, Auditorium B, 1600 Clifton Road, NE, Atlanta, 
Georgia 30333.
    Status: Open to the public, limited only by the space available.
    Purpose: The Board of Scientific Counselors, NCID, provides 
advice and guidance to the Director, CDC, and Director, NCID, in the 
following areas: program goals and objectives; strategies; program 
organization and resources for infectious disease prevention and 
control; and program priorities.
    Matters to be Discussed: The agenda will focus on:

1. NCID Update.
2. Minority and Women's Health.
3. National Foundation for the Centers for Disease Control and 
Prevention.
4. NCID Fellowship Programs.
5. Emerging Infectious Disease Progress/Plans.
6. Work Group Sessions: Emerging Infectious Disease FY 1997.
    a. Surveillance and Response.
    b. Research.
    c. Prevention and Control.
    d. Infrastructure.
7. Work Group Reports.
8. Strengthening NCID Pathology Capacity.
9. Review of Laboratory Programs in Division of Bacterial and 
Mycotic Diseases and Hospital Infections Program.
10. Special Pathogens Branch, Division of Viral and Rickettsial 
Diseases, Peer Review.

    Other agenda items include announcements/introductions; follow-
up on actions recommended by the Board (December 1995); and 
consideration of future directions, goals, and recommendations.
    Agenda items are subject to change as priorities dictate.
    Written comments are welcome and should be received by the 
contact person listed below prior to the opening of the meeting.

[[Page 18147]]

    Contact Person for More Information: Diane S. Holley, Office of 
the Director, NCID, CDC, M/S C-20, 1600 Clifton Road, NE, Atlanta, 
Georgia 30333, telephone 404/639-0078.

    Dated: April 17, 1996.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 96-10045 Filed 4-23-96; 8:45 am]
BILLING CODE 4163-18-M
Exhibit 10.7.2

AMENDMENT TO EMPLOYMENT AGREEMENT 
FOR T. JOE DANELSON

This Amendment dated effective December 16, 2008 (this Amendment) amends the Employment Agreement by and among PremierWest Bancorp, PremierWest Bank, and T. Joe Danelson dated as of April 21, 2008 (the Employment Agreement).

NOW, therefore, Executive and PremierWest agree as follows:1.           Section 5.8 of the Employment Agreement is amended to add the following provision:In addition, PremierWest shall reimburse Executive for up to an additional $75,000 of costsrelated to the sale of Executives home in Salem, Oregon (Additional Sale Expenses), provided,however, that Executive shall immediately reimburse PremierWest for all amounts paid asAdditional Sale Expenses in the event that, within 24 months following payment of anyAdditional Sale Expenses by PremierWest, Executive is terminated for Cause or Executiveterminates his employment other than for Good Reason.2.         Terms not otherwise defined in this Amendment shall have the meanings set forth in theEmployment Agreement.3.         Except as specifically set forth herein, the Employment Agreement as previouslyexecuted shall continue in full force and effect as written.IN WITNESS WHEREOF, the parties have executed this Amendment as of the date first writtenabove.

|                                      |                                
|------------------------------------- | -------------------------------
|PREMIERWEST BANCORP                   | EXECUTIVE                      
|                                      |                                
|By:__________________________________ | _______________________________
|____________________________          | T. Joe Danelson                
|                                      |                                
|PREMIERWEST BANK                      |                                
|                                      |                                
|By:______________________________     |                                
|____________________________          |                                

- 1 -

---
[Federal Register Volume 60, Number 72 (Friday, April 14, 1995)]
[Notices]
[Pages 19082-19083]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-9224]



-----------------------------------------------------------------------

INTERSTATE COMMERCE COMMISSION
[Finance Docket No. 32677]


Penske Dedicated Logistics Corporation--Control Exemption-- 
Leaseway Transportation Corporation and Its Carrier Subsidiaries

AGENCY: Interstate Commerce Commission.

ACTION: Notice of exemption.

-----------------------------------------------------------------------

SUMMARY: Under 49 U.S.C. 10505, the Commission exempts from the 
regulatory requirements of 49 U.S.C. 11343 et seq., the acquisition and 
control of Leaseway Transportation Corporation (LTC) and its 26 motor 
carrier subsidiaries by Penske Dedicated Logistics Corporation (PDLC). 
PDLC is under common control with a rail carrier.

DATES: This exemption is effective on April 14, 1995. Petitions to 
reopen must be filed by May 4, 1995.

ADDRESSES: Send pleadings referring to Finance Docket No. 32677 to: (1) 
Office of the Secretary, Case Control Branch, Interstate Commerce 
Commission, 1201 Constitution Avenue, NW., Washington, DC 20423; and 
(2) Andrew K. Light, Scopelitis, Garvin, Light & Hanson, 1777 Market 
Tower, 10 West Market Street, Indianapolis, IN 46204.

FOR FURTHER INFORMATION CONTACT: Joseph H. Dettmar, (202) 927-5660. 
[TDD for hearing impaired: (202) 927-5721.]

SUPPLEMENTARY INFORMATION: Additional information is contained in the 
Commission's decision. To purchase a copy of the full decision, write 
to, call, or pick up in person from: Dynamic Concepts, Inc., Interstate 
Commerce Commission Building, 1201 Constitution Avenue, NW., Room 2229, 
Washington, DC 20423. Telephone: (202) 289-4357/4359. [Assistance for 
the hearing impaired is available through TDD services (202) 927-5721.]


    Decided: April 7, 1995.

    [[Page 19083]] By the Commission, Chairman Morgan, Vice Chairman 
Owen, and Commissioners Simmons and McDonald.
Vernon A. Williams,
Secretary.
[FR Doc. 95-9224 Filed 4-13-95; 8:45 am]
BILLING CODE 7035-01-P
**Certification      **
**Pursuant      to Section 906 of the Sarbanes-Oxley Act of 2002**

| 1. | the                Report fully complies with the requirements of Section 13(a) or 15(d)                of                the Securities Exchange Act of 1934;                and |
|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2. | the                information contained in the Report fairly presents, in all material                respects, the financial condition and results of operations of ZVUE                Corporation |
|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| **By:**/s/**JEFF OSCODAR**                                                                                 |
|------------------------------------------------------------------------------------------------------------|
| Jeff                Oscodar                                                                                |
| President                & Chief Executive Officer (Principal Executive                Officer)        |
|                                                                                                       |
| **By:**/s/**THOMAS HILLMAN**                                                                               |
| Thomas                Hillman                                                                              |
| Interim                Chief Financial Officer (Principal Financial and Accounting                Officer) |

----
EXHIBIT 23.1

                   CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS


As independent public accountants, we hereby consent to the incorporation of our
report included in Liberty Technologies, Inc.'s Form 10-K, into the Company's
previously filed Form S-8 Registration Statement (File No. 33-73070) filed with
the Securities and Exchange Commission on December 20, 1993, Form S-8
Registration Statement (File No. 33-68744) filed with the Securities and
Exchange Commission on September 13, 1993, and Form S-8 Registration Statement
(File No. 33-67032) filed with the Securities and Exchange Commission on August
12, 1993.


                                              ARTHUR ANDERSEN LLP

Philadelphia, Pa.
  April 15, 1997